Scholar Rock Holding Corp (SRRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRRK | AMGN | BMY | VRTX | GILD |
| Company | Scholar Rock Holding Corp | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 26.71 | 290.84 | 58.35 | 454.30 | 89.81 |
| High | 29.95 | 295.48 | 58.79 | 457.54 | 90.45 |
| Low | 26.39 | 288.78 | 57.62 | 449.04 | 89.27 |
| Last | 29.69 | 294.57 | 58.65 | 450.76 | 90.34 |
| Change | +3.02 | +4.67 | +0.42 | +0.39 | +0.58 |
| % Change | +11.32% | +1.61% | +0.72% | +0.09% | +0.65% |
| Volume | 468,998 | 1,204,006 | 3,545,791 | 660,360 | 1,572,586 |
| 20-Day Average Volume | 884,855 | 2,899,555 | 12,213,749 | 1,326,373 | 7,317,087 |
| Previous Close | 26.67 | 289.90 | 58.23 | 450.37 | 89.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 28.34 | 306.27 | 56.25 | 477.93 | 90.95 |
| 20-Day Raw Stochastic | 70.13% | 35.13% | 72.82% | 8.87% | 31.59% |
| 20-Day Relative Strength | 61.15% | 39.79% | 61.46% | 41.41% | 54.40% |
| Weighted Alpha | -25.64 | +3.93 | +27.03 | +18.53 | +26.78 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | 24% Sell | 80% Buy |
| Previous Opinion | 88% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 88% Buy | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.74% since 11/15/24 | +3.69% since 11/15/24 | +4.16% since 11/15/24 | -3.02% since 11/15/24 | +1.96% since 11/15/24 |
| Low | 25.75 on 11/18/24 | 275.56 on 11/19/24 | 55.84 on 11/18/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 29.83 on 11/22/24 | 295.48 on 11/22/24 | 58.83 on 11/20/24 | 468.88 on 11/18/24 | 90.44 on 11/22/24 |
| 1-Month | |||||
| %Chg | +1.72% since 10/22/24 | -8.01% since 10/22/24 | +10.99% since 10/22/24 | -4.90% since 10/22/24 | +2.23% since 10/22/24 |
| Low | 25.75 on 11/18/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 31.24 on 10/29/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +229.25% since 08/22/24 | -9.39% since 08/22/24 | +22.97% since 08/22/24 | -5.89% since 08/22/24 | +18.75% since 08/22/24 |
| Low | 6.76 on 10/03/24 | 275.56 on 11/19/24 | 47.38 on 08/23/24 | 445.00 on 11/21/24 | 75.91 on 08/23/24 |
| High | 35.38 on 10/08/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +152.78% since 05/22/24 | -4.96% since 05/22/24 | +38.31% since 05/22/24 | +0.92% since 05/22/24 | +32.94% since 05/22/24 |
| Low | 6.76 on 10/03/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 35.38 on 10/08/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,496,712 | 155,830,816 | 118,100,752 | 115,983,328 | 111,864,840 |
| Shares Outstanding, K | 93,615 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -165,790,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -64,480,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.47 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.66 on 11/12/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.98 | 49.47 | 0.00 | 20.01 |